A carregar...
Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy
Individualized therapies that are tailored to a patient's genetic composition will be of tremendous value for treatment of cancer. Recently, Kirsten ras (KRAS) status has emerged as a predictor of response to epidermal growth factor receptor (EGFR) targeted therapies. In this article, we will d...
Na minha lista:
Main Authors: | , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2009
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2686726/ https://ncbi.nlm.nih.gov/pubmed/19386128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1756-8722-2-18 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
A carregar...